www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-deSmartHouse Media GmbHhttp://finanzen.net/images/finanzen_net.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/Alkermes_Presents_Positive_Preclinical_Data_on_Naltrexone_for_Extended_Release_Injectable_Suspension_at_Annual_Meeting_of_Controlled_Release_Society_753000Alkermes, Inc. (NASDAQ: ALKS) today announced positive preclinical results which demonstrated naltrexone for extended-release injectable suspension (XR-NTX) was more effective in an animal model of substance abuse compared to oral ...http://www.finanzen.net/nachricht/Alkermes_Presents_Positive_Preclinical_Data_on_Naltrexone_for_Extended_Release_Injectable_Suspension_at_Annual_Meeting_of_Controlled_Release_Society_753000http://www.finanzen.net/nachricht/Alkermes_Presents_Positive_Data_on_Proprietary_Molecules_Targeting_Opioid_Receptors_748278Alkermes, Inc. (NASDAQ: ALKS) today announced positive preclinical results for three proprietary molecules targeting opioid receptors, including ALKS 33. Data from two preclinical studies demonstrated that the three molecules showed ...http://www.finanzen.net/nachricht/Alkermes_Presents_Positive_Data_on_Proprietary_Molecules_Targeting_Opioid_Receptors_748278http://www.finanzen.net/nachricht/Alkermes_Initiates_Phase_3_Clinical_Study_of_VIVITROL_R_for_the_Treatment_of_Opioid_Dependence_746368Alkermes, Inc. (NASDAQ: ALKS) today announced the initiation of a phase 3 clinical trial of VIVITROL® (naltrexone for extended-release injectable suspension) for the treatment of opioid dependence. The multi-center study is designed to ...http://www.finanzen.net/nachricht/Alkermes_Initiates_Phase_3_Clinical_Study_of_VIVITROL_R_for_the_Treatment_of_Opioid_Dependence_746368http://www.finanzen.net/nachricht/Alkermes_Expands_Common_Stock_Repurchase_Program_and_Raises_Fiscal_Year_2009_Financial_Expectations_741474Alkermes, Inc. (NASDAQ: ALKS) today announced that its Board of Directors has authorized the expansion of its common stock repurchase program by an additional $40 million following the receipt of a $40 million payment from Eli Lilly ...http://www.finanzen.net/nachricht/Alkermes_Expands_Common_Stock_Repurchase_Program_and_Raises_Fiscal_Year_2009_Financial_Expectations_741474http://www.finanzen.net/nachricht/Alkermes_Corporate_Presentation_to_be_Webcast_at_the_Friedman_Billings_Ramsey_Spring_Investor_Conference_731646Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Friedman, Billings, Ramsey & Co., Inc. on Wednesday, May 28, 2008 at 1:35 p.m. EDT. The presentation will be webcast from the Grand ...http://www.finanzen.net/nachricht/Alkermes_Corporate_Presentation_to_be_Webcast_at_the_Friedman_Billings_Ramsey_Spring_Investor_Conference_731646http://www.finanzen.net/nachricht/Alkermes_to_Host_Conference_Call_to_Discuss_Fiscal_Year_2008_Financial_Results_726577Alkermes, Inc. (NASDAQ: ALKS) will host a conference call at 4:30 p.m. EDT on Thursday, May 22, 2008 to discuss the company’s financial results for the fiscal year ended March 31, 2008. Management will review the results and provide ...http://www.finanzen.net/nachricht/Alkermes_to_Host_Conference_Call_to_Discuss_Fiscal_Year_2008_Financial_Results_726577http://www.finanzen.net/nachricht/Alkermes_Corporate_Presentation_to_be_Webcast_at_the_Bank_of_America_Securities_Health_Care_Conference_722500Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Bank of America Securities on Wednesday, May 14, 2008 at 7:00 p.m. ET (4:00 p.m. PT). The presentation will be webcast from the ...http://www.finanzen.net/nachricht/Alkermes_Corporate_Presentation_to_be_Webcast_at_the_Bank_of_America_Securities_Health_Care_Conference_722500http://www.finanzen.net/nachricht/Alkermes_Corporate_Presentation_to_Be_Webcast_at_the_Morgan_Stanley_Global_Healthcare_Unplugged_Conference_715151Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Morgan Stanley on Thursday, May 1, 2008 at 1:40 p.m. EDT. The presentation will be webcast from the Ritz-Carlton, Key Biscayne, ...http://www.finanzen.net/nachricht/Alkermes_Corporate_Presentation_to_Be_Webcast_at_the_Morgan_Stanley_Global_Healthcare_Unplugged_Conference_715151http://www.finanzen.net/nachricht/Alkermes_Announces_Restructuring_695659Alkermes, Inc. (NASDAQ: ALKS) announced that it is restructuring its operations following the termination by Eli Lilly and Company (Lilly) of the AIR® Insulin program, as announced March 7, 2008. With this restructuring, Alkermes ...http://www.finanzen.net/nachricht/Alkermes_Announces_Restructuring_695659http://www.finanzen.net/nachricht/Alkermes_Corporate_Presentation_to_Be_Webcast_at_the_Cowen_and_Company_Health_Care_Conference_692832Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Cowen and Company on Tuesday, March 18, 2008 at 3:10 p.m. EDT. The presentation will be webcast from The Marriott Copley Place in ...http://www.finanzen.net/nachricht/Alkermes_Corporate_Presentation_to_Be_Webcast_at_the_Cowen_and_Company_Health_Care_Conference_692832